Covid-19: relationship with kidney diseases. Literature review

N. Tomilina, N. Frolova, L. Artyukhina, E. N. Djakova, A. Frolov, K. E. Loss, M. Zubkin, I. G. Kim, G. V. Volgina
{"title":"Covid-19: relationship with kidney diseases. Literature review","authors":"N. Tomilina, N. Frolova, L. Artyukhina, E. N. Djakova, A. Frolov, K. E. Loss, M. Zubkin, I. G. Kim, G. V. Volgina","doi":"10.28996/2618-9801-2021-2-147-159","DOIUrl":null,"url":null,"abstract":"COVID-19 is a severe acute respiratory disease caused by the SARS-CoV-2 virus. Although COVID-19 is characterized mainly by diffuse alveolar damage and acute respiratory failure, in some cases COVID-19 may acquire extra-respiratory features, including renal dysfunction that has existed earlier or developed de novo. The reasons for the extra-respiratory manifestations are biological properties of SARS-CoV-2 based on its multiple organ tropism. It has been shown that at least 50% of patients hospitalized for COVID-19 have proteinuria, hematuria, and signs of renal dysfunction, which in some cases reaches the degree of acute kidney injury (AKI). Here we present a review that discusses the clinical aspects and possible pathophysiological mechanisms of kidney damage in COVID-19. It is believed that renal damage observed in this disease is the result of a complex mechanism induced directly or indirectly by SARS-CoV-2 with the development of acute kidney injury. Two main pathophysiological mechanisms of kidney damage in COVID-19 are discussed. The first of them is the direct cytopathic effect of SARS-CoV-2 on the renal epithelium with the development of acute tubulonecrosis. The second mechanism is the cytokine storm syndrome that results from hyperactivation of the immune system with the development of acute renal and multiorgan infl ammatory damage accompanied by hypoxia, persistent hypotension, rhabdomyolysis, hyperactivation of the coagulation cascade, and microcirculation disorders. From a clinical point of view, it should be noted that signs of kidney damage are associated with an increase in the severity of COVID-19 and a poor outcome of the disease, and the prognosis becomes the worst with the development of AKI (the risk of death may increase by 5.3 times). The incidence of COVID-19 in patients with ESRD is higher than in the general population. The most typical for these patients is a severe course of the disease, which determines the increased mortality in comparison with the general population, caused by a respiratory failure with hyperactive infl ammation, cytokine storm, hemodynamic, and multiple organ failures. © 2021 JSC Vidal Rus. All rights reserved.","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephrology and Dialysis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.28996/2618-9801-2021-2-147-159","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

COVID-19 is a severe acute respiratory disease caused by the SARS-CoV-2 virus. Although COVID-19 is characterized mainly by diffuse alveolar damage and acute respiratory failure, in some cases COVID-19 may acquire extra-respiratory features, including renal dysfunction that has existed earlier or developed de novo. The reasons for the extra-respiratory manifestations are biological properties of SARS-CoV-2 based on its multiple organ tropism. It has been shown that at least 50% of patients hospitalized for COVID-19 have proteinuria, hematuria, and signs of renal dysfunction, which in some cases reaches the degree of acute kidney injury (AKI). Here we present a review that discusses the clinical aspects and possible pathophysiological mechanisms of kidney damage in COVID-19. It is believed that renal damage observed in this disease is the result of a complex mechanism induced directly or indirectly by SARS-CoV-2 with the development of acute kidney injury. Two main pathophysiological mechanisms of kidney damage in COVID-19 are discussed. The first of them is the direct cytopathic effect of SARS-CoV-2 on the renal epithelium with the development of acute tubulonecrosis. The second mechanism is the cytokine storm syndrome that results from hyperactivation of the immune system with the development of acute renal and multiorgan infl ammatory damage accompanied by hypoxia, persistent hypotension, rhabdomyolysis, hyperactivation of the coagulation cascade, and microcirculation disorders. From a clinical point of view, it should be noted that signs of kidney damage are associated with an increase in the severity of COVID-19 and a poor outcome of the disease, and the prognosis becomes the worst with the development of AKI (the risk of death may increase by 5.3 times). The incidence of COVID-19 in patients with ESRD is higher than in the general population. The most typical for these patients is a severe course of the disease, which determines the increased mortality in comparison with the general population, caused by a respiratory failure with hyperactive infl ammation, cytokine storm, hemodynamic, and multiple organ failures. © 2021 JSC Vidal Rus. All rights reserved.
Covid-19:与肾脏疾病的关系文献综述
COVID-19是由SARS-CoV-2病毒引起的严重急性呼吸道疾病。尽管COVID-19的主要特征是弥漫性肺泡损伤和急性呼吸衰竭,但在某些情况下,COVID-19可能具有呼吸外特征,包括早期存在或新发的肾功能障碍。出现呼吸外表现的原因是SARS-CoV-2基于多器官趋向性的生物学特性。有研究表明,至少50%的COVID-19住院患者有蛋白尿、血尿和肾功能不全的迹象,在某些情况下达到急性肾损伤(AKI)的程度。本文综述了COVID-19肾损害的临床方面和可能的病理生理机制。我们认为,在该病中观察到的肾脏损害是SARS-CoV-2直接或间接引起急性肾损伤的复杂机制的结果。本文讨论了新冠肺炎肾损害的两种主要病理生理机制。首先是SARS-CoV-2在急性肾小管坏死发生时对肾上皮的直接细胞病变作用。第二种机制是细胞因子风暴综合征,它是免疫系统过度激活,并发急性肾和多器官炎症损害,并伴有缺氧、持续性低血压、横纹肌溶解、凝血级联过度激活和微循环障碍。从临床角度来看,需要注意的是,肾脏损害的迹象与COVID-19严重程度的增加和疾病预后不良相关,并且随着AKI的发展,预后最差(死亡风险可能增加5.3倍)。ESRD患者中COVID-19的发病率高于一般人群。这些患者最典型的是病程严重,这决定了与一般人群相比死亡率增加,由呼吸衰竭伴炎症过度活跃、细胞因子风暴、血流动力学和多器官衰竭引起。©2021 JSC Vidal Rus。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nephrology and Dialysis
Nephrology and Dialysis Medicine-Nephrology
CiteScore
0.60
自引率
0.00%
发文量
14
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信